Search Results

You searched for : anti-PD-1  

	Zumutor Biologics Advances Cancer Care with Novel Immunotherapy ZM008: A First-in-Class Anti LLT1 Antibody As the ZM008-001 clinical trial progresses, the medical community eagerly awaits the results, which could lead the way for a new era in cancer ... Jun 13
	Evaxion Biotech announces Clinical Collaboration to evaluate Keytruda in melanoma patients Latest news updates... Oct 26
	ImmixBio and BeiGene to evaluate combination of IMX-110 and Tislelizumab in solid tumors Latest Pharma News Update... Aug 31
	Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106 Latest Pharma Update... Aug 23
	GSK and iTeos Therapeutics announce development and commercialisation collaboration for EOS-448 With this collaboration GSK is uniquely positioned with access to antibodies that synergistically target all three known CD226 checkpoints - TIGIT, CD96 and PVRIG.... Jun 14
	Bristol Myers Squibb announces LAG-3-Blocking antibody Relatlimab and Nivolumab fixed-dose Combination Significantly improves progression-free Survival vs. Opdivo (nivolumab) in patients... May 22
	Bristol Myers Squibb Announces RELATIVITY-047, a Trial Evaluating Anti-LAG-3 Antibody Relatlimab and Opdivo The antibody is indicated for patients with previously untreated Metastatic or unresectable melanoma... Mar 27
	BioInvent and Transgene receive CTA approval for Phase l/lla trial of oncolytic virus BT-001 in solid tumors BioInvent and Transgene, today announced they have received regulatory approval in Belgium for a clinical trial application (CTA) for a Phase l/lla study of ... Dec 21
	FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA ... Dec 18
	FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA Patients with newly diagnosed esophageal and GEJ cancer face an aggressive disease with a poor prognosis, despite the currently available treatment options... Dec 17
	KEYTRUDA Plus LENVIMA Combination Demonstrated Statistically Significant Improvement in Overall Survival ... Dec 16
	Merck Receives Positive EU CHMP Opinion for KEYTRUDA as First-Line Treatment for Metastatic Microsatellite Instability ... Dec 11
	KEYTRUDA plus LENVIMA met the trial’s primary endpoint of progression-free survival LENVIMA plus everolimus were evaluated versus sunitinib for the first-line treatment of patients with advanced renal cell carcinoma... Nov 10
	Dr. Reddy’s E777 ( Denileukin Diftitox) pre clinical data shows tumor growth inhibition ... Nov 10
	Merck received US FDA approval for Keytruda FDA approves expanded indication for Merck’s KEYTRUDA (pembrolizumab) in adult patients with relapsed or refractory classical hodgkin lymphoma (cHL) ... Oct 16
	FDA Approves Expanded Indication for Merck’s KEYTRUDA in Adult Patients With classical Hodgkin Lymphoma (cHL) ... Oct 15
	Late-breaking ESMO presentation shows Libtayo® (cemiplimab) monotherapy increases overall survival in first-line advanced non-small cell lung cancer with PD-L1 Positive pivotal trial data for the investigational use of PD-1 inhibitor Libtayo® (cemiplimab) in first-line locally advanced or metastatic non-small cell lung ... Sep 21
	Junshi Biosciences receives FDA Breakthrough Therapy Designation for Toripalimab Major breakthrough for treatment of Nasopharyngeal Carcinomar ... Sep 11
	Merck’s KEYTRUDA Receives Two New Approvals in Japan Keytruda would be soon launched in Japan for the treatment of cancerous tumors... Aug 27
	Compugen Reports 4th Quarter and Full Year 2019 Result Compugen Ltd., a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today declared their 4th and full year report.... Feb 21
20 Matching result(s) found!

Trending Now
	Decoding Fatty Liver Disease: Symptoms, Reversibility, and the MASLD/NAFLD SpectrumAugust 07, 2026
	Heart-Healthy Dietary Patterns: Translating Clinical Nutrition Guidelines into Daily MealsAugust 07, 2026
	Prostate Health Awareness: What Every Indian Man Needs to KnowAugust 07, 2026
	Testosterone Levels Explained: Normal Ranges by Age, Causes of Imbalance, and What to DoAugust 07, 2026
	“AI can read a chest X-ray in 1.3 seconds” says Dr. Marios Loukas, President and Dean of the School of Medicine, St. George’s UniversityAugust 06, 2026
	UK Mental Healthcare Leader Care ADHD To Open Its First Clinic in Bengaluru This October, Bringing NHS-Backed ADHD Care Model to IndiaAugust 06, 2026
	Aster DM Quality Care Reports Strong Q1 FY27: Revenue Up 20 Per Cent to Rs 2,597 Cr, Operating EBITDA Up 30 Per CentAugust 06, 2026
	What Happens to Your Body During an All-Nighter?August 06, 2026
	Childhood Obesity in India: A Growing Public Health Crisis That Demands Urgent AttentionAugust 06, 2026
	Screen Time Effects on Children: What Every Indian Parent and Paediatrician Needs to KnowAugust 06, 2026
	Kidney Transplant Recipient Defeats CancerAugust 05, 2026
	Fermenta Biotech Lists on India’s National Stock ExchangeAugust 05, 2026
	Asia Pacific leaders warn attacks against health and gender are undoing decades of progressAugust 05, 2026
	Understanding Long-Term Impacts of Air Purification on ImmunityAugust 05, 2026
	Understanding Epigenetics: How Lifestyle Changes Your DNAAugust 05, 2026
	CARE Hospitals to Offer Free Vascular Health Check on National Vascular DayAugust 05, 2026
	Breastfeeding Myths That New Mothers Should Stop BelievingAugust 05, 2026
	Why Modern Lifestyle Causes Chronic InflammationAugust 05, 2026
	Endometriosis Awareness: Understanding the Silent Condition Affecting Millions of Indian WomenAugust 05, 2026
	A Complete Guide to Pregnancy Health Tips for Indian Women: Nutrition, Wellness, and What Every Expectant Mother Should KnowAugust 05, 2026